Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)
Clinical trial NCT07179770 · RECRUITING
Trial details
- NCT number
- NCT07179770
- Sponsor
- NYU Langone Health
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2028-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.